Schedule III Doesn't Fix Gun Rights for Cannabis Users — Here's Why

The Rescheduling Celebration Has a Caveat

When the Trump administration moved state-licensed medical marijuana to Schedule III in April 2026, the cannabis industry celebrated a historic milestone. The end of 280E tax penalties, improved banking access, and reduced federal stigma were all genuine victories worth acknowledging.

But amid the celebrations, one critical limitation received far less attention: marijuana's move to Schedule III does not restore gun rights for cannabis users. The Department of Justice has explicitly stated that the rescheduling has no impact on federal firearms law, meaning millions of cannabis consumers remain legally prohibited from purchasing or possessing guns under federal statute.

This creates a situation where the federal government simultaneously acknowledges marijuana's medical legitimacy by moving it to Schedule III while maintaining that anyone who uses it — even legally, even medicinally, even in a state that has authorized it — is too dangerous to exercise their Second Amendment rights.

For consumers tracking how Schedule III is changing the legal landscape state-by-state — what it does and doesn't fix — find a dispensary near you on Budpedia to see how local retailers are framing the change at the counter.

The Federal Firearms Prohibition Explained

Under 18 U.S.C. § 922(g)(3), it is illegal for any person "who is an unlawful user of or addicted to any controlled substance" to possess firearms or ammunition. The key phrase is "any controlled substance" — not just Schedule I substances. This means that moving marijuana from Schedule I to Schedule III does nothing to change the firearms prohibition because the statute applies equally to users of all scheduled substances.

When you purchase a firearm from a licensed dealer, you must complete ATF Form 4473, which asks whether you are "an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance." Answering "yes" disqualifies you from the purchase. Answering "no" while being a cannabis user constitutes a federal felony — lying on a federal firearms form.

The DOJ's Solicitor General filed papers making this position explicit, stating that the Schedule III reclassification "does not affect the proper resolution" of pending Supreme Court cases involving gun rights for marijuana users. The federal government's position is clear: rescheduling changes tax treatment, research access, and regulatory classification, but it does not change who is prohibited from possessing firearms.

The Scale of the Problem

This is not a theoretical concern affecting a handful of people. An estimated 55 million Americans used marijuana in the past year, according to federal survey data. In states with legal recreational programs, cannabis use rates are significantly higher. Every one of these individuals is technically prohibited from firearms ownership under federal law, regardless of whether their cannabis use is legal under state law.

The practical enforcement reality is complex. Federal authorities rarely pursue firearms charges against cannabis users who are otherwise law-abiding, particularly in states where marijuana is legal. But the prohibition creates legal jeopardy that could be activated at any time, and it forces cannabis consumers to choose between their Second Amendment rights and their state-legal cannabis use.

For medical cannabis patients specifically, the situation is particularly unjust. Patients who use marijuana to treat chronic pain, PTSD, epilepsy, or other qualifying conditions are forced to choose between their prescribed treatment and their constitutional rights. No such choice is imposed on patients prescribed opioids, benzodiazepines, or other Schedule III substances with far greater risks of impairment and addiction.

Why Schedule III Doesn't Help

The firearms prohibition statute was written broadly to cover all controlled substances, not just the most restricted categories. This was presumably intentional — Congress wanted to ensure that substance users were prohibited from firearms regardless of their specific substance of choice. But the consequence is that marijuana's position on the scheduling hierarchy is irrelevant to the firearms question.

For the gun rights prohibition to change, one of several things would need to happen: Congress would need to amend 18 U.S.C. § 922(g)(3) to exclude marijuana users, the courts would need to find the provision unconstitutional as applied to cannabis consumers, or marijuana would need to be descheduled entirely — removed from the Controlled Substances Act altogether rather than merely moved to a lower schedule.

The Supreme Court has pending cases that could potentially address the constitutional question. Following its 2022 decision in New York State Rifle & Pistol Association v. Bruen, which established a historical-tradition test for firearms regulations, lower courts have split on whether the cannabis-user prohibition can survive constitutional scrutiny. Some courts have found that the historical record does not support disarming people solely for using an intoxicating substance, while others have upheld the prohibition.

The DOJ's Contradictory Position

Acting Attorney General Todd Blanche recently stated that the DOJ is reconsidering whether to continue pursuing prosecutions of marijuana consumers for possessing guns, as the administration works to reduce regulatory burdens on firearms owners and businesses. This creates an odd dynamic: the DOJ simultaneously defends the legal prohibition in court filings while signaling potential reluctance to enforce it.

This enforcement discretion approach offers cold comfort to cannabis users. While it may reduce the likelihood of prosecution, it does nothing to resolve the legal uncertainty. Cannabis consumers who own guns remain federal felons whether or not the government chooses to prosecute them. They cannot legally purchase new firearms, they cannot pass background checks without committing an additional felony, and they exist in a state of perpetual legal vulnerability.

What Actually Needs to Happen

The most straightforward solution is legislative. Several bills have been introduced in Congress that would remove cannabis users from the prohibited persons list under federal firearms law. The Marijuana Opportunity Reinvestment and Expungement (MORE) Act would deschedule cannabis entirely, resolving the firearms issue as a byproduct of broader reform.

Alternatively, targeted legislation could amend § 922(g)(3) to exclude state-legal marijuana users without requiring full descheduling. This narrower approach might attract bipartisan support given the current administration's stated interest in both cannabis reform and firearms rights expansion.

The judicial path remains possible but uncertain. The Supreme Court could resolve the circuit split on this issue in an upcoming term, but the timeline is unpredictable and the outcome far from certain.

The Broader Lesson

The gun rights gap illustrates a fundamental truth about the Schedule III rescheduling: it is a significant but incomplete reform. Moving marijuana to Schedule III addresses specific tax, banking, and research barriers while leaving numerous federal consequences intact. Immigration consequences, federal employment prohibitions, public housing restrictions, and firearms disabilities all remain in force for cannabis users regardless of scheduling status.

For cannabis consumers who also value their Second Amendment rights — a demographic that cuts across political lines — Schedule III is a step forward that highlights how far the journey toward full normalization still extends. Until marijuana is either descheduled entirely or Congress acts to harmonize firearms law with the reality of legal cannabis, millions of Americans will continue navigating an impossible choice between two activities their state governments have deemed perfectly legal.